Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 509 | 409 | 615 | 277 | 421 |
| Receivables | 389 | 474 | 287 | 180 | 371 |
| Inventories | 237 | 141 | 131 | 75 | 72 |
| TOTAL | $1,176 | $1,047 | $1,046 | $562 | $911 |
| Non-Current Assets | |||||
| PPE Net | 10 | 11 | 11 | 12 | 13 |
| TOTAL | $10 | $11 | $11 | $12 | $13 |
| Total Assets | $1,186 | $1,058 | $1,057 | $574 | $924 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 879 | 784 | 799 | 700 | 718 |
| Accrued Expenses | 176 | 154 | 173 | 166 | 193 |
| TOTAL | $3,159 | $938 | $972 | $866 | $911 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,573 | 5,236 | 4,899 | 3,975 | 3,509 |
| TOTAL | $3,573 | $5,236 | $4,899 | $3,975 | $3,509 |
| Total Liabilities | $6,732 | $6,174 | $5,871 | $4,841 | $4,420 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 111,887 | 111,887 | 111,887 | 111,857 | 111,857 |
| Common Shares | 1,119 | 1,119 | 1,119 | 1,119 | 1,119 |
| Retained earnings | -139,458 | -138,994 | -138,662 | -138,082 | -137,284 |
| TOTAL | $-5,546 | $-5,116 | $-4,814 | $-4,267 | $-3,496 |
| Total Liabilities And Equity | $1,186 | $1,058 | $1,057 | $574 | $924 |